SREBF1 and metabolic dysfunction-associated steatohepatitis: Similarly, low levels of PPAR-α also affect the NASH progression, which was treated by seed extract of chicory through modulating the PPAR-α level [26], where activation of PPAR-α inhibited the SREBP-1c pathway [27].